Indication
Muscle spasticity of spinal origin
Muscle spasticity of spinal origin is a motor disorder characterized by involuntary, velocity-dependent increases in muscle tone and exaggerated stretch reflexes resulting directly from injury or disease of the spinal cord. Read more about Muscle spasticity of spinal origin
139 drugs 91 manufacturers
Drugs that treat it
Common Muscle spasticity of spinal origin therapies.
DANTROLENE SODIUM
BACLOFEN
TIZANIDINE HCL
BACLOFEN
TIZANIDINE HCL
BACLOFEN
TIZANIDINE HCL
BACLOFEN
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonMuscle spasticity of spinal origin is a motor disorder characterized by involuntary, velocity-dependent increases in muscle tone and exaggerated stretch reflexes resulting directly from injury or disease of the spinal cord.
Commonly associated with conditions such as spinal cord injury, transverse myelitis, and multiple sclerosis, it affects the neuromuscular system below the anatomical level of the spinal lesion.
Pathophysiologically, the condition is driven by upper motor neuron disruption that impairs descending inhibitory pathways, leading to heightened motor neuron excitability, hyperreflexia, painful flexor or extensor spasms, and clonus.
- veritaneuro.com
Muscle spasticity of spinal origin is a motor disorder characterized by involuntary, velocity-dependent increases in muscle tone and exaggerated stretch reflexes resulting directly from injury or disease of the spinal cord
- nih.gov
Commonly associated with conditions such as spinal cord injury, transverse myelitis, and multiple sclerosis, it affects the neuromuscular system below the anatomical level of the spinal lesion
- mayoclinic.org
Commonly associated with conditions such as spinal cord injury, transverse myelitis, and multiple sclerosis, it affects the neuromuscular system below the anatomical level of the spinal lesion
- msktc.org
Commonly associated with conditions such as spinal cord injury, transverse myelitis, and multiple sclerosis, it affects the neuromuscular system below the anatomical level of the spinal lesion Pathophysiologically, the condition is driven by upper motor neuron disruption that impairs descending inhibitory pathways, leading to heightened motor neuron excitability, hyperreflexia, painful flexor or extensor spasms, and clonus
- nih.gov
Pathophysiologically, the condition is driven by upper motor neuron disruption that impairs descending inhibitory pathways, leading to heightened motor neuron excitability, hyperreflexia, painful flexor or extensor spasms, and clonus
- nih.gov
Pathophysiologically, the condition is driven by upper motor neuron disruption that impairs descending inhibitory pathways, leading to heightened motor neuron excitability, hyperreflexia, painful flexor or extensor spasms, and clonus
- neuromodulation.com
Pathophysiologically, the condition is driven by upper motor neuron disruption that impairs descending inhibitory pathways, leading to heightened motor neuron excitability, hyperreflexia, painful flexor or extensor spasms, and clonus
Personalize your experience
Follow Muscle spasticity of spinal origin and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.